Differential glucose repression in common yeast strains in response to HXK2 deletion by Kümmel, Anne et al.
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2010
Differential glucose repression in common yeast strains in response to HXK2
deletion
Kümmel, Anne; Ewald, Jennifer Christina; Fendt, Sarah-Maria; Jol, Stefan Jasper; Picotti, Paola;
Aebersold, Ruedi; Sauer, Uwe; Zamboni, Nicola; Heinemann, Matthias
Abstract: Under aerobic, high glucose conditions, Saccharomyces cerevisiae exhibits glucose repression
and thus a predominantly fermentative metabolism. Here, we show that two commonly used prototrophic
representatives of the CEN.PK and S288C strain families respond differently to deletion of the hexokinase
2 (HXK2) – a key player in glucose repression: In CEN.PK, growth rate collapses and derepression
occurs on the physiological level, while the S288C descendant FY4 Dhxk2 still grows like the parent
strain and shows a fully repressed metabolism. A CEN.PK Dhxk2 strain with a repaired adenylate
cyclase gene CYR1 maintains repression but not growth rate. A comparison of the parent strain’s
physiology, metabolome, and proteome revealed higher metabolic rates, identical biomass, and byproduct
yields, suggesting a lower Snf1 activity and a higher protein kinase A (PKA) activity in CEN.PK. This
study highlights the importance of the genetic background in the processes of glucose signaling and
regulation, contributes novel evidence on the overlap between the classical glucose repression pathway
and the cAMP/PKA signaling pathway, and might have the potential to resolve some of the conflicting
findings existing in the field.
DOI: 10.1111/j.1567-1364.2010.00609.x
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: http://doi.org/10.5167/uzh-79180
Originally published at:
Kümmel, Anne; Ewald, Jennifer Christina; Fendt, Sarah-Maria; Jol, Stefan Jasper; Picotti, Paola; Aeber-
sold, Ruedi; Sauer, Uwe; Zamboni, Nicola; Heinemann, Matthias (2010). Differential glucose repression
in common yeast strains in response to HXK2 deletion. FEMS Yeast Research, 10(3):322-332. DOI:
10.1111/j.1567-1364.2010.00609.x
 
 
1 
 
Differential glucose repression in common yeast strains  
in response to HXK2 deletion 
 
Anne Kümmel1$, Jennifer Christina Ewald1;2;5, Sarah-Maria Fendt1;2;5, Stefan Jasper Jol1;5, Paola Picotti1,  
Ruedi Aebersold1;2;3;4, Uwe Sauer1;2, Nicola Zamboni1;2, Matthias Heinemann1;2;6;# 
 
1. Institute of Molecular Systems Biology, ETH Zurich, Zurich, Switzerland 
2. Competence Center for Systems Physiology and Metabolic Diseases, Zurich, Switzerland 
3. Institute for Systems Biology, Seattle, WA, USA 
4. Faculty of Science, University of Zurich, Zurich, Switzerland 
5. Life Science Zurich PhD Program on Systems Biology of Complex Diseases 
6. Molecular Systems Biology, Groningen Biomolecular Sciences and Biotechnology Institute, Groningen, 
The Netherlands 
 
$ Present address: Novartis Institutes for BioMedical Research, Basel, Switzerland. 
 
# To whom correspondence should be addressed. 
E-mail: heinemann@imsb.biol.ethz.ch or m.heinemann@rug.nl 
Phone: +41 44 632 63 66 
Fax: +41 44 633 10 51 
 
 
 
2 
 
 
Abstract  
Under aerobic, high glucose conditions, Saccharomyces cerevisiae exhibits glucose repression and thus a 
predominantly fermentative metabolism. Here, we show that two commonly used prototrophic 
representatives of the CEN.PK and S288C strain families respond differently to deletion of the hexokinase 
2 (HXK2) – a key player in glucose repression: In CEN.PK, growth rate collapses and derepression occurs 
on the physiological level, while the S288C descendent FY4 Δhxk2 still grows like the parent strain and 
shows a fully repressed metabolism. A CEN.PK Δhxk2 strain with a repaired adenylate cyclase gene CYR1 
maintains repression but not growth rate. A comparison of the parent strains’ physiology, metabolome, 
and proteome revealed higher metabolic rates, identical biomass and byproduct yields suggesting a 
lower Snf1 activity and a higher PKA activity in CEN.PK. This study highlights the importance of the 
genetic background in the processes of glucose signaling and regulation, contributes novel evidence on 
the overlap between the classical glucose repression pathway and the cAMP/PKA signaling pathway and 
might have the potential to resolve some of the conflicting findings existing in the field. 
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Introduction 
Under high glucose conditions and despite the presence of oxygen, the yeast Saccharomyces cerevisiae 
shows an almost exclusively fermentative metabolism, which is characterized by excretion of ethanol 
and absence of respiratory activity (Carlson, 1999, Rolland, et al., 2002). This effect is called catabolite or 
glucose repression and is reminiscent of the Warburg effect that occurs in several tumor cells (Johnston 
& Kim, 2005). Next to the distinct physiology, invertase (SUC2) expression/activity is also frequently used 
in the community as a reporter for the state of glucose repression. 
Glucose repression in yeast is primarily realized by the Hxk2/Snf1 pathway (Gancedo, 1998, Rolland, et 
al., 2002). While quite some molecular details of this pathway have been elucidated, a holistic 
understanding of its complete functioning still remains elusive (Bisson & Kunathigan, 2003). It is clear, 
however, that the glucose phosphorylating enzyme hexokinase 2 (Hxk2) has a pivotal regulatory role 
(Randez-Gil, et al., 1998, de la Cera, et al., 2002, Ahuatzi, et al., 2004, Ahuatzi, et al., 2007). There is 
certain indication that the glycolytic flux might be the signal that determines the degree of glucose 
repression (Jiang, et al., 2000, Elbing, et al., 2004, Otterstedt, et al., 2004). A classical experiment in the 
field of glucose repression is the deletion of the Hxk2. Using auxotrophic strains, it was originally found 
that glucose repression is relieved as identified on the basis of increased SUC2 expression/activity 
(Zimmermann & Scheel, 1977, Entian, 1980, Ma & Botstein, 1986). Subsequent work, however, has 
shown that when Hxk2 is not present, hexokinase 1 (Hxk1) can also maintain glucose repression (Rose, et 
al., 1991, De Winde, et al., 1996). 
Such conflicting findings with respect to the effect of HXK2 deletions on glucose repression can likely be 
explained by the fact that the used strains were not genetically identical. In some strains, the 
redundancy in the form of the Hxk1 isoenzyme might compensate for the loss of Hxk2. Alternatively, the 
cAMP/protein kinase A (PKA) pathway, which also has a role in regulating Snf1 (Hedbacker, et al., 2004, 
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Slattery, et al., 2008), could realize Hxk1/2-independent degree of glucose repression (Mbonyi, et al., 
1990, Zaragoza, et al., 1999). Overall, conflicting findings such as those on the effect of HXK2 deletions 
with respect to glucose repression and the application of different means to assess glucose repression 
(i.e. SUC2 expression/activity vs. physiological quantification of glucose repression) certainly hamper 
further progression of the field.  
Focusing on the eventual physiological manifestation of glucose repression, we comparatively 
investigated prototrophic representatives of two important yeast strain families that are frequently used 
to study glucose signaling and regulation and that show different responses to HXK2 deletions: The 
CEN.PK strain, a prominent yeast reference strain selected in a multi-lab effort (van Dijken, et al., 2000) 
shows on the physiological level a completely derepressed metabolism upon deletion of the HXK2 gene. 
In contrast, the FY4 strain (Winston, et al., 1995) – a descendent of the first sequenced yeast strain and a 
prototrophic version of the strain BY strain with which most strain libraries were generated – 
physiologically fully retains the state of glucose repression when the same gene is deleted. A recent 
genome-wide analysis of nucleotide-level variations in S. cerevisiae strains has revealed that the FY4 
strain – which is nearly identical to the BY4716 strain investigated in this analysis (Brachmann, et al., 
1998) – and the CEN.PK strain are rather similar: genetic variation was found in only a small fraction of 
the genome (80% of the single nucleotide polymorphisms in CEN.PK in 18% of the genome) and only 17 
genes in CEN.PK carry a whole or a partial (longer than 500 bps in size) deletion in comparison to BY4716 
(with 41% of those genes not having assigned a biological function) (Schacherer, et al., 2007). 
In this paper we set out to investigate the differences in these two strains under high glucose conditions. 
Specifically, we aimed at elucidating why these two strains respond differently on physiological level 
upon a deletion of the HXK2 gene and whether the known defect in the CYR1 gene (encoding adenylate 
cyclase; involved in cAMP synthesis) in CEN.PK (Vanhalewyn, et al., 1999) is responsible for the different 
behavior. We compare the physiology, metabolome, and proteome of the two yeast strains and a variant 
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of one of them. We find significant differences between these strains providing compelling evidence for 
the effect of the genetic background on major metabolic pathways like those involved in glucose 
signaling in yeast. Furthermore, our study provides support for an earlier hypothesized link between the 
classical glucose repression pathway and the glucose activated cAMP/PKA signaling pathway. 
Materials and Methods 
Strains and culture conditions 
The strains used in this study are listed in Tab. 1. In CEN.PK JT4, the HXK2 gene was deleted by the short 
flanking homology method using the loxP-kanMX4-loxP gene disruption cassette (Guldener, et al., 1996). 
The deletion cassette was amplified from pUG6, using as a forward primer 5'-
TCTTTGTTGCACCTTCGCCACTGTCTTATCTACAAAACTACTTCGTACGCTGCAGGTC-3', which includes 18 
nucleotides complementary to pUG6 and a 40-nucleotide extension corresponding to the region -150 to 
-110 upstream of the start codon of the HXK2 ORF, and as a reverse primer 5'-
AGTACGCAAGCTATCTAGAGGAAGTGTAGAGAGGGTTAAATAGTGGATCTGATATCACCTA-3', which includes 
21 nucleotides complementary to pUG6 and 40 nucleotides corresponding to the region +1851 to +1811 
downstream of the start codon of the HXK2 ORF. Deletion of the HXK2 ORF was confirmed by PCR on 
genomic DNA extracted from G418R transformants. 
In all experiments, cells were grown in minimal defined medium with glucose as sole carbon source. The 
medium was prepared from autoclaved salt and glucose solutions and sterile filtered solutions of 
vitamins and trace metals to reach concentrations as described in (Verduyn, et al., 1992). Liquid 
precultures with 10 g/l glucose were inoculated by colonies from YPD plates. In all experiments, the 
glucose concentration was 10 g/l and the temperature was maintained at 30°C. Phtalate buffer (10 mM 
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for shake flask experiments, 90 mM for 13C labeling experiments) was used to maintain pH at a value of 
5. 
Sequencing of HXK2 gene 
The HXK2 gene was amplified by PCR from the FY4 and CEN.PK genome using a primers pair (5' 
CTTTGAAAAGGTTGTAGGAA 3' and 5' TAGAAAAAGGGCACCTTCTT 3') to amplify a region of 1571 bp 
containing the gene. The resulting PCR product was cleaned with the QIAquick PCR Purification kit 
(Qiagen, Valencia, CA, USA), and was send to Microsynth AG (Balgach, Switzerland) for sequencing with 
the PCR primers and two internal primers (5' ATATCGGAACAAACATCGTA 3' and 5' 
TACACTGACCCAGAAACTAA 3'). The resulting four sequenced fragments were aligned and compared with 
the YGL253W gene from the Saccharomyces Genome Database (Tettelin, et al., 1997). 
Biomass and extracellular metabolite concentrations 
 Biomass concentrations were monitored by measuring optical density (OD) at 600 nm with a 
spectrophotometer (Pharmacia Novaspec II). The biomass dry weight was calculated using an earlier 
determined OD-to-biomass dry weight (DW) correlation coefficient of 0.486 
OD
lgDW /
 for FY4 and 0.52 
OD
lgDW /
 for CEN.PK strains. To determine the extracellular concentrations of glucose, ethanol, acetate, 
pyruvate, and glycerol, 1 ml samples were taken and centrifuged for 4 min at 4000 rpm at 4°C. Unless 
otherwise noted, the supernatant was analyzed with an HPLC system (Agilent HP1100), equipped with a 
polymer column (Aminex HPX-87, BioRad). As eluent 5 mM H2SO4 was used and the column was heated 
to 60°C. The compounds were detected and quantified with a refractive index (RI) detector and an 
UV/Vis-detector (DAD). For absolute quantification, calibration curves with external standards for the 
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corresponding pure substance obtained from Sigma were used. Growth rates, µ, and biomass yields, 
glc
xY , were calculated by linear regression (Matlab, function regress.m) using the following equations,  
 txx  )ln()ln( 0 , (1) 
  glcglc
glc
x ccYxx  00 , (2) 
respectively, based on the biomass concentrations, x, and extracellular glucose concentrations, cglc 
obtained from all biological replicates. The yields of ethanol, acetate, glycerol, and pyruvate were 
calculated by using equations analog to Eqn. 2. The remaining uptake and production rates were 
determined from the estimated values. 
Respiratory TCA cycle activity 
The respiratory TCA cycle activity was determined from 13C-labeling experiments, where 20% of the 
glucose in the medium was uniformly labeled (≥ 99% enrichment, obtained from Cambridge Isotope 
Labs). These experiments were carried out in deep well plates with a culture volume of 1.2 ml and the 
biomass concentration was measured at 600 nm (Spectra MAX Plus, Bucher Biotec AG). Cultures were 
harvested during exponential growth at ODs between 0.8 and 1.3 and centrifuged at 4°C and 4000 rpm 
for 3 min. Supernatant and cell pellets were separately frozen at -40°C. Extracellular metabolite 
concentrations in the supernatant were determined via HPLC-RI/DAD methods as described above. 
To determine the labeling patterns in proteogenic amino acids, samples were prepared and analyzed by 
GC-MS. Cell pellets were hydrolyzed in 180 µl 6 M HCl at 105 °C for 12 h and the hydrolysate dried at 
95°C. The free amino acids were derivatized at 85 °C for 1 h using 20 µl dimethylformamide and 20 µl N-
(tert-butyldimethylsilyl)-N-methyltrifluoroacetamide +1% tert-butyldimethylchlorosilane. GC-MS analysis 
was carried out using a GC (series 6890N, Agilent Technologies) in combination with a mass 
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spectrometer (5973, Agilent Technologies) (Fischer, et al., 2004). The respiratory TCA cycle activity was 
calculated from the fraction of mitochondrial oxaloacetate from anaplerosis, which was calculated from 
13C-labeling patterns using FiatFlux (Zamboni, et al., 2005). 
Intracellular metabolite concentrations 
Intracellular metabolite concentrations of two biological and two technical replicates were determined 
from samples withdrawn from culture at an OD of approximately 1.5. To quench metabolism and extract 
intracellular metabolites, the following procedure was applied (adapted from (de Koning & van Dam, 
1992, Gonzalez, et al., 1997)). Samples of 1-4 ml were taken at each sampling time point and quenched 
in methanol at -40°C. For the determination of the cAMP concentrations a sample volume of 10 ml was 
taken. After centrifuging for 3 min at 14000 rpm in a rotor pre-cooled to -9°C, they were frozen at -40°C. 
Intracellular metabolites were extracted by incubation in 75% ethanol for 3 min at 95°C. The supernatant 
was collected after centrifuging in a pre-cooled rotor (-9°C). 
For quantification by GC-TOF, two sample aliquots were derivatized with either TMS-agent (N-Methyl-N-
(trimethylsilyl) trifluoroacetamide, Fluka) or TBDMS-agent (N-tert-butyldimethylsilyl-N-
methyltrifluoroacetamide, Fluka). The samples were separated via GC on a HP5-MS column (Hewlett-
Packard, length 30m x ID 0.25 x film 0.25 µm) and injected for MS analysis to a TOF spectrometer 
(Pegasus III, Leco). Detailed information on process parameters are described in (Ewald, et al., 2009). 
Leco ChromaTOF software (version 2.32) was used for acquisition. An autosampler (MPS2, Gerstel) 
controlled by Gerstel Maestro software was used to derivatize samples just-in-time prior to injection to 
the GC-TOF system. 
For quantification by LC-MS/MS, an ion-pairing reverse phase LC method was adapted from (Luo, et al., 
2007). The mobile phase was composed of eluent A (aqueous solution of 10 mM tributylamine and 15 
mM acetic acid) and eluent B (methanol); the gradient profile was as follows: t = 0 min, 0% B; t = 15 min, 
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55% B; t = 27 min, 66% B; t = 28 min, 100% B. The end-capped C18 column (Synergi Hydro RP, 2.1 x 150 
mm, 4 µm particles; Phenomenex) was employed.  
The column was equilibrated for 20 min before each injection, the flow rate was 200 µL/min, the column 
temperature was controlled at 40°C; the injection volume was 8 µL. For tandem MS analysis, an Applied 
Biosystems/MDS Sciex 4000 QTRAP mass spectrometer (AB/MDS Sciex) was coupled to the LC. The 
Analyst software (version 1.4.2, AB/MDS Sciex) was used for acquisition and peak integration. All 
analyses were performed in negative mode and selected reaction-monitoring mode with Q1 and Q3 set 
to unit resolution. Ion spray voltage, auxiliary gas temperature, nebulizer gas, auxiliary gas, curtain gas 
and collision gas were set to -4200 V, 650°C, 65, 40, 10, 4 (arbitrary units), respectively. Nitrogen 
(Pangas) was used as curtain and collision gas.  
Declustering potential, collision energy and collision cell exit potential were optimized separately for 
each compound. To obtain temporal resolution of 1 Hz or greater for each transition, the run was divided 
into five segments and the dwell time for each transition was set to 50 ms. 
To calculate intracellular concentrations, we used a conversion factor of 2 µl/mgCDW. Standard errors 
m for the sample means m are estimated from the data and for display on logarithmic scale 
transformed according to error propagation based on the derivative method: 
mm
m m
m

 



ln
log  
Protein abundances 
To determine protein concentration, duplicate samples of 25 ml were harvested on ice and washed twice 
with 5 ml washing buffer (20 mM HEPES pH 7.5, 2 mM EDTA). During washing, the protein samples were 
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centrifuged for 5 min at 5000 rpm at 4°C and the supernatant discarded afterwards. Cell pellets were 
frozen at -80°C. 
For protein extraction, the cell pellets were thawed and resuspended in an ice cold lysis buffer 
containing 20 mM TrisHCl pH 8.0, 2 mM DTT, 100 mM KCl, 10 mM EDTA, and complete yeast protease 
inhibitors cocktail (Roche), using 1 ml of lysis buffer per gram of yeast. Yeast cells were lysed by glass 
bead beating, and lysed cells were centrifuged to remove cellular debris. The supernatant was 
transferred to a fresh tube and the protein concentration in the extract was determined by Bradford 
assay. Proteins were precipitated by adding six volumes of cold (-20°C) acetone and resolubilized in a 
digestion buffer containing 8M urea and 0.1 M NH4HCO3. A 100 µg protein aliquot of each yeast protein 
sample was transferred to a fresh tube and mixed with an equal amount of 15N-labeled yeast proteins (cf. 
below). To digest the proteins, they were reduced with 12  mM dithiotreitol for 30 min at 35°C and 
alkylated with 40 mM iodoacetamide for 45 min at 25°C, in the dark. Samples were diluted with 0.1 M 
NH4HCO3 to a final concentration of 1.5 M urea and sequencing grade porcine trypsin (Promega) was 
added to a final enzyme:substrate ratio of 1:100. The digestion was stopped by acidification with formic 
acid to a final pH<3. Peptide mixtures were cleaned on Sep-Pak tC18 cartridges (Waters) eluted with 60% 
acetonitrile. Peptides were evaporated on a vacuum centrifuge to dryness, resolubilized in 0.1% formic 
acid and immediately analyzed. 
Protein abundances were determined by a selective/multiple reaction monitoring (S/MRM) based mass 
spectrometry approach as follows. For each target protein, a set of five proteotypic peptides 
preferentially observed in shotgun proteomics experiments (King, et al., 2006) or predicted to have 
suitable MS properties (Mallick, et al., 2007) was selected for S/MRM analysis. For each peptide, 3-8 
transitions were calculated, corresponding to fragment ions of the y-series. Fragment ions with m/z 
above the precursor ion m/z were prioritized. The precursor/fragment ion transitions were used to 
detect by S/MRM the peptides of interest in whole S. cerevisiae protein digests and to trigger acquisition 
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of the full fragment ion spectra of the peptides (S/MRM-triggered MS2), as previously described (Picotti, 
et al., 2008). Each SRM assay was validated by acquiring a full tandem mass spectrum of the 
corresponding peptide. 
Samples were analyzed on a hybrid triple quadrupole/ion trap mass spectrometer (4000QTrap, AB/MDS-
Sciex) equipped with a nanoelectrospray ion source. Chromatographic separations of peptides were 
performed on a Tempo nano LC system (Applied Biosystems) coupled to a 15 cm fused silica emitter, 75 
µm diameter, packed with a Magic C18 AQ 5 mm resin (Michrom BioResources). Peptides were loaded 
on the column from a cooled (4°C) Tempo autosampler and separated with a linear gradient of 
acetonitrile/water, containing 0.1% formic acid, at a flow rate of 300 nl/min. A gradient from 5 to 30% 
acetonitrile in 30 or 60 min was used. The pipeline used to analyze MS2 data and extract the optimal 
coordinates for the S/MRM assays is described elsewhere (Picotti, et al., 2008). 
For the quantitative analysis, a 15N-labeled yeast digest was derived from a yeast batch culture that 
displayed diauxic growth on minimal medium with 20 g/l glucose and 15N-labeled ammonium as nitrogen 
source. To gain high coverage of metabolic proteins, aliquots from the different phases (growth on 
glucose, transient phase and growth on ethanol) of this experiment were mixed. The such heavy labeled 
protein mixture was used as an internal standard and was spiked into each sample at a 1:1 ratio before 
digestion. The three most intense S/MRM transitions from each validated peptide and for the 
corresponding 15N-labelled analogue were chosen for quantitative analysis. Quantitation was performed 
in scheduled-S/MRM mode (retention time window, 300 s; target scan time, 2.4 s), using the acquisition 
software Analyst 1.5, beta version (Applied Biosystems/MDS Sciex). Peak height was determined with 
Multiquant 1.0.0.1 software (Applied Biosystems/MDS Sciex) after confirming for each peptide the co-
elution of all 6 transitions. Peak height ratios of the sample transition and internal standard transition 
were used to corrected for spray efficiency and ionization differences between runs. 
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To calculate the average protein abundances from the two biological replicates, mean values of peptide 
amounts were calculated from the transitions, mean values for proteins from the peptide mean values, 
and finally the two biological replicates were averaged. A conservative estimation of the standard 
deviation was calculated from the variance of the pool of all measured transitions for the respective 
protein. 
Osmotic shock experiments 
To determine the survival rate after hyperosmotic shock, we adapted a method reported in (Beney, et 
al., 2001). Colony forming units (CFU) for an aliquot of yeast culture exposed to hyperosmotic shock and 
a non-treated aliquot - both from an exponentially growing culture - were counted. For hyperosmotic 
shock treatment, an aliquot of 1 ml was mixed with 9 ml autoclaved glycerol/water solution (116.9 g 
glycerol in 50 ml water, approx. 65 mPa) and left for 40 min at room temperature. Both treated and non-
treated samples were diluted 33000 and 66000 times respectively in autoclaved isotonic NaCl solution (9 
g/l) and 200 µl spread on YPD plates. After two days of incubation at 30°C, photographs were taken and 
the CFU counted. The survival rate was calculated as the ratio of CFU of treated versus non-treated 
samples. 
Transcription factor analysis of protein abundances 
Transcription factors, which are more often than by chance associated with the subset of proteins that 
are 3-times lower abundant in CEN.PK compared to FY4 were determined by a statistical enrichment 
analysis adopted from (Boyle, et al., 2004). We here applied the documented transcription factor-gene 
associations reported by (Teixeira, et al., 2006). For each transcription factor (TF) that has at least one 
interaction with any of the measured proteins a p-value based on a hypergeometric distribution was 
calculated:  
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Here, N is the total number of proteins measured and n the number of proteins that are 3-times lower 
abundant in CEN.PK. Mj and kj are the number of measured proteins and the number of measured, 3-
times lower abundant proteins in CEN.PK respectively, that interact with TF j. The such calculated p-
value gives the probability that the TF has at least the observed number of interactions with the subset 
of lower abundant proteins. Detailed results are provided in Supplementary Table 1. 
Results  
Between the two here compared strains, there is one known genetic difference that likely is relevant for 
glucose signaling and regulation: a point mutation in the CEN.PK's CYR1 gene encoding the adenylate 
cyclase prevents this strain to show the otherwise typical cAMP increase upon sudden glucose excess 
(Vanhalewyn, et al., 1999), thus in principle lacking the PKA pathway as an alternative mean for glucose 
repression. To assess whether the lacking CYR1 activation in CEN.PK could be the reason for the different 
responses to an HXK2 deletion, we also analyzed a CEN.PK strain with repaired CYR1, called JT4. In all 
experiments, the strains were grown aerobically in batch mode on glucose minimal medium and samples 
were taken at high residual glucose concentrations.  
Physiological comparison 
First, we determined the strains’ physiology. Here, CEN.PK and JT4 are absolutely identical in terms of 
rates and yields (Tab. 2). This was also expected as the point mutation in CYR1 impairs the glucose- and 
acidification-induced cAMP increase in de-repressed cells, while glucose-repressed cells are usually 
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thought to be not affected by this mutation (Vanhalewyn, et al., 1999). The FY4 strain, in contrast, shows 
a lower growth rate than the two CEN.PK strains (Tab. 2). The yields, however, are very similar in all 
strains (Tab. 2). Further, all strains show a physiologically fully repressed metabolism with practically 
absent respiratory TCA cycle activity as determined by 13C metabolic flux analysis (Fig. 1). Overall, while 
the relative intracellular flux distribution is identical in all analyzed strains, the CEN.PK and the JT4 strain 
realize much higher metabolic rates than the FY4. 
Significant differences occur when HXK2 is deleted: CEN.PK Δhxk2 shows a significantly reduced growth 
rate (0.22 h-1) and a derepressed metabolism reaching a biomass yield of biomass yield 0.43 gDW gglucose-1 
which is comparable to fully respiring, glucose-limited cultures (van Dijken, et al., 2000). This finding can 
be further substantiated by the pronounced effect on the respiratory TCA cycle activity, which increases 
from 0.024 (±0.003) to a high value of 0.735 (±0.020) in the HXK2 deletion mutant (cf. Fig. 1B). This 
increase, however, is at least partially caused by the reduction of the growth rate provoked by the 
mutation. In CEN.PK, Blank and Sauer demonstrated that the respiratory TCA cycle activity inversely 
correlates with growth rate (Blank & Sauer, 2004). Nevertheless, even after correcting for the growth 
rate related increase of the respiratory TCA cycle activity, a large portion of the observed increase in the 
HXK2 deletion mutant can still be attributed to the HXK2 deletion itself (Fig. 1B). 
In contrast, the FY4 Δhxk2 strain almost behaves like the corresponding parent strain with an almost 
identical growth rate (0.32 h-1), identical biomass yield (0.16 gDW gglucose-1) and significantly repressed 
respiratory TCA cycle activity (Fig. 1B). A second independently generated HXK2 deletion in FY4 and in a 
FY4-related strain (YSBN6) confirmed that HXK2 deletion in the FY4 strain indeed has basically no effect 
on the physiology (cf. Supplementary Information).  
In JT4, the HXK2 deletion results in a very small relief from glucose repression but not to the same extent 
as in the CEN.PK strain (biomass yield 0.19 gDW gglucose-1 in JT4 Δhxk2; cf. Fig. 1 for the respiratory TCA 
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cycle activity). As in CEN.PK, the HXK2 deletion in JT4 also causes a drastic reduction of the growth rate 
(0.17 h-1). The comparison of CEN.PK Δhxk2 and JT4 Δhxk2, where the only difference is the repaired 
point mutation, demonstrates that the adenylate cyclase-mediated PKA pathway restores the 
physiological state of glucose repression in JT4 Δhxk2, but not the growth rate.  
Overall, these findings indicate that in CEN.PK Hxk2 has an exclusive role for realizing the physiological 
state of glucose repression, while ‘backup’ systems for glucose repression must exist in JT4 and FY4. The 
question is whether the FY4 strain upon HXK2 deletion also draws on the PKA pathway to maintain 
glucose repression on physiological level. Alternatively, Hxk1 could also act as backup system or it is also 
possible that Hxk1 is active in FY4 already in the first place. Towards answering this question, we 
therefore performed an in-depth omics analysis of the wild-type parent strains. Using state of the art 
proteomics (Lange, et al., 2008) and metabolomics (Ewald, et al., 2009) techniques we determined the 
absolute amounts of 36 intracellular metabolites from central metabolism and the concentrations of 84 
enzymes relative to an internal standard. 
Omics comparison 
On the metabolome level, the CEN.PK and the JT4 strains are very similar. However, we found significant 
differences between the CEN.PK/JT4 strains and the FY4 strain (Fig. 2; Supplementary File 1). In 
particular, the metabolites in the upper glycolysis and the pentose phosphate pathway exhibit higher 
concentrations in the CEN.PK (on average 2-fold). The metabolite data from TCA cycle intermediates 
indicate different substrate-to-product ratios in this part of the metabolic network (cf. Supplementary 
Figure). Particularly, several reactions (such as those catalyzed by enolase, isocitrate dehydrogenase, and 
succinate dehydrogenase), which are known to be influenced by glucose repression (Schuurmans, et al., 
2008), are further shifted from equilibrium (cf. Supplementary Figure), indicating a lower catalytic 
capacity for these reactions (Kummel, et al., 2006). 
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Also, the proteome data revealed that the CEN.PK and JT4 strains are almost identical, while significant 
differences exist between the CEN.PK/JT4 strains and the FY4 (Fig. 3; Supplementary File 2). In general, 
the CEN.PK/JT4 strains have lower protein levels than the FY4 strain. In different parts of the central 
metabolic network, proteins were identified that are more than 8-fold less abundant in CEN.PK/JT4 
compared to the FY4; e.g. the hexokinase 1 (Hxk1), the -ketoglutarate dehydrogenase (Kgd1), or the 
,-trehalose-phosphate synthase (Tsl1). As a general trend, proteins with a lower abundance in 
CEN.PK/JT4 are proteins known to be glucose repressed (i.e. Hxk1, Glk1, Tdh1, Eno1, Pyk2, and Ald4) 
(Navarro-Avino, et al., 1999, Rodriguez, et al., 2001, Schuurmans, et al., 2008). In fact, many of the less 
abundant proteins in CEN.PK have been shown to be transcriptionally upregulated upon deletion of 
HXK2 (Westergaard, et al., 2007). 
Differential transcription factor activity 
In a statistical enrichment analysis of the proteome data we asked which transcription factors could have 
caused the differential protein expression patterns (cf. Material and Methods for details). This analysis 
revealed that the activities of the transcription factors Mig1, Nrg1, and Nrg2 are likely more active in 
CEN.PK (transcription factor p-value < 0.02). These repressors – known to be involved in glucose 
repression (Horak, et al., 2002) – are all downstream of Snf1, suggesting a lower Snf1 activity in CEN.PK. 
The enrichment analysis further suggested the two transcription factors Msn2 and Msn4 to be less active 
in CEN.PK (p-values < 0.002). In addition to these activators’ involvement in the general stress response, 
they are also known to mediate hyperosmotic shock resistance (Martinez-Pastor, et al., 1996). In fact, we 
found that CEN.PK is much less resistant to hyperosmotic stress, as no CEN.PK cells survived a 40 min 
residence in a high osmolar glycerol solution, while the survival rate was 16% (±7%) for FY4. Stress 
resistance is known to be repressed by high PKA activity (Thevelein & de Winde, 1999) and as Msn2 was 
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shown to be inversely correlated with cAMP levels and PKA activity (Gorner, et al., 1998) this suggests 
that CEN.PK has a higher PKA activity than FY4. 
Differential cAMP concentrations  
As a proxy for PKA activity, we determined the cAMP concentrations in the three wild-type strains and 
the corresponding HXK2 deletion strains. We found that the CEN.PK and JT4 strains have an 
approximately 2-fold higher cAMP level than the FY4 strain (Fig. 4) potentially causing the higher basal 
PKA activity in these strains that was inferred from the above analysis. While the HXK2 deletion strains of 
CEN.PK and FY4 exhibit similar cAMP levels as the corresponding parent strains, the cAMP level in the JT4 
Δhxk2 strain was found to be significantly higher than in its parent strain – likely resulting in an increased 
PKA activity. 
Discussion 
We found that CEN.PK and JT4 are virtually identical on all levels under high glucose conditions. These 
two strains, however, are very different compared to the FY4 strain. We found much higher metabolic 
rates in the CEN.PK strains, while the relative intracellular flux distribution is identical in both strain 
families. The higher metabolic rates in the CEN.PK strain might be facilitated by an increased glucose 
uptake/glucose phosphorylation. 
Despite the increased metabolic rates, the CEN.PK strains exhibit lower expression levels of many 
(known glucose repressed) enzymes. As identified by the statistical enrichment analysis, the differential 
protein expression pattern points to differential activity of the repressors Mig1, Nrg1, and Nrg2, which 
are targets of the kinase Snf1 being one of the key regulators for glucose repression (Santangelo, 2006). 
Such an increased glucose repression on the protein level invoked by the Hxk2/Snf1-pathway might be 
the result of the higher glycolytic fluxes in the CEN.PK strains, as glycolytic flux was found to correlate 
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with the degree of glucose repression (Elbing, et al., 2004, Otterstedt, et al., 2004). As we found 
practically identical Hxk2 expression levels in both strains (CEN.PK/FY4 = 1.24 ± 0.21; cf. Supplementary 
File 2) and also identical HXK2 amino acid sequences, the increased Hxk2 activity (i.e. the decreased Snf1 
activity) in CEN.PK compared to FY4 is not due to different Hxk2 sequences or expression levels.  
The decreased Snf1 activity in CEN.PK could also be caused by such increased PKA activity as PKA might 
have the potential to inactivate Snf1 activity (Haurie, et al., 2004, Hedbacker, et al., 2004, Slattery, et al., 
2008). Indeed, our experiments suggested a higher basal PKA activity in the CEN.PK strains. As the JT4 
strain was found to be identical to the CEN.PK strain on all levels, the point mutation has obviously no 
effect in the wild-type CEN.PK. Hence, this mutation cannot be the reason for the observed differences in 
the CEN.PK and FY4 proteomes and metabolomes, which are likely rather a result of the differential Snf1 
and PKA activity. 
The different physiological responses upon the HXK2 deletion in the CEN.PK and JT4 strains indicate that 
an intact CYR1 is able to partly maintain glucose repression on the physiological level in a HXK2 deletion 
background. Indeed, the JT4 Δhxk2 strain has likely an increased PKA activity compared to JT4 as 
indicated by a significantly higher cAMP concentration in JT4 Δhxk2. In fact, a role for cAMP/PKA in 
catabolite repression was suggested earlier (Eraso & Gancedo, 1984, Thompson-Jaeger, et al., 1991).  
Finally, we are still left with the question why CEN.PK and FY4 respond so differently on the physiological 
level to a HXK2 deletion. The polymorphism in the CYR1 can be excluded for two reasons: (i) repairing 
the CYR1 defect in CEN.PK Δhxk2 restores the physiological repression state but not the drop in the 
growth rate, while in FY4 Δhxk2 growth rate is also unaltered; (ii) cAMP levels in FY4 and FY4 Δhxk2 are 
identical indicating unaltered PKA activity in these two strains. (In contrast, we found increased cAMP 
levels in JT4 Δhxk2 compared to JT4 pointing to an increased PKA activity in the HXK2 deletion strain). 
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Thus, we hypothesize that in FY4 Hxk1 might be used a backup to (i) maintain a high glycolytic flux and to 
(ii) sustain a Hxk(1/2)/Snf1 dependent glucose repression. This might not be possible in CEN.PK. 
Conclusion 
This paper reports a comparative multi-omic analysis of two important and commonly used yeast strains 
and a variant of one of them under high glucose conditions. We found significant differences in the 
metabolome, proteome and physiology of the two investigated yeast strain families and in the way how 
these strains realize glucose repression on the physiological level. Further, we generated novel evidence 
on the overlap between the classical glucose repression pathway and the glucose activated cAMP/PKA 
signaling pathway. The identified strain differences highlight the effects of genetic backgrounds on major 
metabolic pathways like those involved in glucose signaling and regulation. Although this unbiased 
comparison does not comprehensively answer all open questions it represents a starting point for 
further analysis that will likely reveal additional mechanisms involved in the phenomena reported. 
Nevertheless, the results of our comparative study with two commonly used yeast strain families – 
performed with identical analytical platforms and identical conditions – will presumably have the 
potential to resolve some conflicting findings that exist in the field or at least provide possible 
explanations for unexplainable or unexpected observations.  
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Tables 
Table  1: Yeast strains used in this work. 
  Strain   Relevant genotype   Source or reference  
 CEN.PK 113-7D   MATa   Euroscarf, (van Dijken, et al., 2000) 
CEN.PK Δhxk2   CEN.PK  113-7D hxk2::kanMX4   (Blank & Sauer, 2004) 
CEN.PK JT4   MATa LCR1   M. Luttik, pers. comm.  
CEN.PK JT4 Δhxk2   CEN.PK  JT4 hxk2::kanMX4   this study  
FY4   MATa   (Winston, et al., 1995) 
FY4 Δhxk2   FY4 hxk2::kanMX4   C. Boone, pers. comm.  
 
Table  2: Physiological parameters of aerobic glucose-growing batch cultures in shake flasks. 
  strain     biomass   glucose   ethanol   acetate   glycerol   pyruvate  
     
yield (g gglc-1) 
CEN.PK   wt   0.114 ± 0.004   -   0.41 ± 0.02   0.011 ± 0.001   0.027 ± 0.002   0.0032 ± 0.0002  
  JT4   0.107 ± 0.005   -   0.37 ± 0.02   0.008 ± 0.001   0.029 ± 0.002   0.0029 ± 0.0002  
FY4   wt   0.113 ± 0.004   -   0.40 ± 0.03   0.008 ± 0.001   0.033 ± 0.004   0.0036 ± 0.0002  
     
rates (g gDW-1 h-1) 
CEN.PK   wt   0.46 ± 0.005   4.04 ± 0.14   1.66 ± 0.10   0.044 ± 0.004   0.109 ± 0.009   0.013 ± 0.001  
  JT4   0.45 ± 0.006   4.21 ± 0.20   1.55 ± 0.13   0.034 ± 0.005   0.122 ± 0.010   0.012 ± 0.001  
FY4   wt   0.33 ± 0.009   2.92 ± 0.13   1.16 ± 0.11   0.023 ± 0.003   0.096 ± 0.013   0.011 ± 0.001  
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Figure legends 
Figure 1: Respiratory TCA cycle activities.  A: Exemplary scheme on metabolic fluxes for high and low 
glucose repression. Under high glucose repression (left), most of the flux through glycolysis is directed to 
ethanol excretion. Such, the respiratory TCA cycle activity as determined by the displayed equation is 
low. On the contrary, a less glucose repressed metabolism (right) is characterized by a higher respiratory 
TCA cycle activity as a higher fraction of the glycolytic flux is directed to the cyclic TCA cycle flux; glc: 
glucose; etoh: ethanol; oaa: oxaloacetate; akg: α-ketoglutarate; B: Respiratory TCA cycle activities in the 
different strains as determined in 13C-labeling experiments from absolute flux values. The gray parts of 
the bars for the Δhxk2 mutants of the CEN.PK strains indicate the increase in respiratory TCA cycle 
activity that is related to the growth rate reduction caused by the gene deletion (as determined from 
(Blank & Sauer, 2004)). 
Figure 2: Metabolite concentration differences in CEN.PK in comparison to FY4 and CEN.PK JT4. The 
natural logarithms of the concentration ratio of CEN.PK and CEN.PK JT4 versus FY4 are displayed. Hence, 
negative numbers correspond to lower concentrations in CEN.PK and CEN.PK JT4. Error bars indicate the 
standard deviation. Metabolite concentrations were determined via GC-TOF (TCA cycle intermediates 
and amino acids) or LC-MS/MS (Embden-Meyerhoff and PP pathway intermediates and co-factors) in 
biological duplicates. Abbreviations: g6p: glucose 6-phosphate; f1p: fructose 1-phosphate; f6p: fructose 
6-phosphate; fdp: fructose 1,6-bisphosphate; dhap: dihydroxyacetonephosphate; 3pg: 3-
phosphoglycerate; pep: phosphoenolpyruvate; 6pgc: 6-phosphogluconate; ru5p-D: D-ribulose 5-
phosphate; r5p: ribose 5-phosphate; xu5p-D: D-xylulose 5-phosphate; cit: citrate; icit: isocitrate; akg: α-
ketoglutarate; succ: succinate; fum: fumarate; mal-L: L-malate; adp: diphosphate; amp: adenosine 
monophosphate; nad: nicotinamide adenine dinucleotide (reduced form). 
Figure 3: Protein concentration differences in CEN.PK in comparison to FY4 and CEN.PK JT4. The natural 
logarithms of the concentration ratio of CEN.PK and CE.PK JT4 versus FY4 are displayed. Hence, negative 
numbers correspond to lower concentration in CEN.PK and CEN.PK JT4. Error bars indicate the standard 
deviation. Here, proteins are displayed that are more than 2-fold higher or lower abundant in CEN.PK in 
comparison to either FY4 or CEN.PK JT4. Protein concentrations were determined via LC-S/MRM in 
relation to an internal standard in biological duplicates. Proteins are labeled by the corresponding gene 
names. Triangles indicate minimal absolute concentration ratios. 
Figure 4: cAMP concentrations in the different strains. Probability associated with a Student's paired t-
test using a two-tailed distribution with homoscedastic variance, only p-values below 0.05 are shown. 
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Supplementary Files 
Spreadsheet (Supplementary File 1 - Metabolite Concentrations.xls) containing the measured metabolite 
concentrations.  
Spreadsheet (Supplementary File 2 - Protein Abundance Differences.xls) containing the 84 measured 
protein concentration differences.  
Table (Supplementary Table 1.pdf) transcription factors that are potentially differently active in CEN.PK 
and FY4.  
Table (Supplementary Table 2.pdf) physiological parameters of aerobic glucose-growing batch cultures in 
13C-labeling experiments performed in deep well plates.  
Figure (Supplementary figure.pdf) Substrate-to-product ratio dierences in CEN.PK in comparison to FY4 
and CEN.PK JT4 and the ratios of the corresponding enzyme amounts. 
Supplementary Information (Supplementary information.pdf) Validation of physiological phenotype of 
the HXK2 deletion in FY4. 
 
 
 
 
